?? IMPORTANT — ACQUISITION STRUCTURE (PLEASE READ FIRST)
This DME company is offered EXCLUSIVELY through a Minority Stake Purchase Agreement (MSA) with a built-in option to acquire 100%. No alternative structures will be considered.
How the MSA Works:

Phase 1 — Closing: Buyer acquires a 49% membership interest. Seller retains 51% solely as owner of record for the Medicare PTAN, NPI, DMEPOS accreditation, and surety bond. This is what allows the company to transfer without triggering the CMS moratorium.
Day-One Operational Control: Despite the 49/51 split on paper, Buyer assumes FULL operational control at closing — company bank account, EFT/Medicare deposits, billing, management, and 100% of economic upside going forward.
Bond & Insurance: Buyer replaces the $50,000 DMEPOS surety bond and general liability coverage at closing (Seller named as additional insured), removing Seller's financial exposure.
Post-Closing Liabilities: All Medicare/Medicaid overpayments, recoupments, audits, and bond-related claims arising from claims submitted on or after closing are 100% Buyer's responsibility, with full indemnification of Seller. Pre-closing liabilities stay with Seller (none — the PTAN has zero billing history).
Phase 2 — Option to Acquire Remaining 51%: Buyer receives an irrevocable option to purchase the Seller's 51% at a fixed price equal to 50% of the original purchase price, exercisable once the CMS moratorium is lifted (or within 24 months of the lift / 36 months from closing, whichever is later).
Payment: Installments over 60 or 90 days, Buyer's choice.
Personal Guaranty: If Buyer is an entity, principals execute a personal guaranty for payment, bond/insurance, and indemnification obligations.

This structure is the only legally clean way to transfer effective ownership and operational control of an active, accredited DMEPOS supplier in a moratorium-affected category without the company losing its enrollment. Draft MSA available to NDA-bound buyers.

Opportunity Overview
Rare opportunity to acquire effective ownership of an established DME company headquartered in Jacksonville, FL — fully licensed, fully accredited, and positioned for immediate scale. The company holds an active Medicare PTAN in good standing with a clean compliance record and ZERO Medicare billing history, eliminating audit, recoupment, and clawback exposure.
Because this transaction uses the MSA structure with retained record ownership, the company can be operationally transitioned without being blocked by the current CMS DMEPOS enrollment moratorium — exceptionally valuable in a market where new Medicare enrollments remain restricted across many regions and product categories.
Key Highlights

Active Medicare PTAN — clean record, zero billing history
Licensed for Medicare in several states
Fully accredited through the Board of Certification/Accreditation (BOC)
All state licenses, surety bonds, and compliance documentation current
Transferable via MSA — not subject to the new-enrollment moratorium
Direct-to-patient shipping model operational
Jacksonville, FL HQ with multi-state reach

Authorized Product Categories

Continuous Glucose Monitoring (CGM) devices and sensors
Orthoses — Off-The-Shelf (OTS)
Ostomy Supplies
Surgical Dressings
Urological Supplies
Oxygen

Inquiries: Serious, financially qualified buyers only. Sign an NDA, provide proof of funds, and confirm willingness to transact under the MSA structure before financials and the draft MSA will be released.